Higher levels of the inflammatory marker C-reactive protein predicted lower reported cognitive function among older breast cancer survivors, according to study results published in Journal of Clinical Oncology.
The findings add to evidence that links chronic inflammation with cognitive problems among cancer survivors, researchers wrote.
Most breast cancer survivors in the U.S. are aged 60 years or older, and as many as half of survivors have cognitive problems following treatment, according to Judith E. Carroll, PhD, associate professor of psychiatry and biobehavioral sciences and faculty